A Global Milestone in Innovative Pancreatic Cancer Therapy

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

BioGate-Precision-UK

More Like This

How Cutting-Edge Immunotherapies Are Redefining Cancer Treatment Options

GlobeNewswire associated0

XBiotech Results from Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treatment for Advanced Pancreatic Cancer

BerGenBio Announces First Patient Entered Into Advanced Adenocarcinoma Lung Cancer Trial

PR Newswire associated0

Biosyngen's first-in-class CAR-T asset targeting solid tumors has entered pivotal phase II trial, Phase I trial data debut at ESMO 2024 Annual Congress

Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy Study

Immunovia's next-generation test to be included in large study of pancreatic cysts funded by the U.S. National Institutes of Health

PR Newswire associated0

Nature Study Reveals: AI and Molecular Dynamics Designed BGM0504 Exhibits Superior Potency

PR Newswire associated0

MGI: Closing the Cancer Care Gap with the Power of Precision Oncology